MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1507.71%
Quick Ratio
1507.71%
Cash Ratio
609.60%
Debt to Asset Ratio
7.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
217,706
653,482
272,639
143,876
Marketable securities
302,290
0
0
124,160
Prepaid expenses and other current assets
18,453
7,295
7,285
9,396
Total current assets
538,449
660,777
279,924
277,432
Property, plant and equipment, gross
-
21,006
-
-
Less accumulated depreciation and amortization
-
6,370
-
-
Property and equipment, net
17,359
14,636
11,563
11,025
Operating right-of-use assets
3,942
2,978
3,125
3,269
Restricted cash
210
210
210
210
Other long-term assets
5,424
4,587
4,555
4,354
Total assets
565,384
683,188
299,377
296,290
Deferred revenue, current
-
0
0
0
Accounts payable
5,996
3,339
6,147
4,660
Accrued expenses and other current liabilities
29,717
41,651
25,298
18,218
Total current liabilities
35,713
44,990
31,445
22,878
Operating lease liabilities, net of current portion
4,588
3,855
4,013
4,142
Total liabilities
40,301
48,845
35,458
27,020
Common stock, 0.0001 par value 300,000,000 shares authorized at june 30, 2026 and december 31, 2025 113,399,202 and 113,133,199 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
11
11
9
9
Additional paid-in capital
1,380,535
1,362,496
922,174
870,092
Accumulated other comprehensive loss
-333
0
0
-24
Accumulated deficit
-855,130
-728,164
-658,264
-600,807
Total stockholders' equity
525,083
634,343
263,919
269,270
Total liabilities and stockholders' equity
565,384
683,188
299,377
296,290
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$302,290K (143.47%↑ Y/Y)Cash and cashequivalents$217,706K (51.32%↑ Y/Y)Prepaid expenses andother current assets$18,453K (96.39%↑ Y/Y)Total current assets$538,449K (94.08%↑ Y/Y)Property and equipment,net$17,359K (57.45%↑ Y/Y)Other long-termassets$5,424K (24.58%↑ Y/Y)Operating right-of-useassets$3,942K (20.59%↑ Y/Y)Restricted cash$210K (0.00%↑ Y/Y)Total assets$565,384K (90.82%↑ Y/Y)Total liabilities andstockholders' equity$565,384K (90.82%↑ Y/Y)Total stockholders'equity$525,083K (95.00%↑ Y/Y)Total liabilities$40,301K (49.15%↑ Y/Y)Accumulated deficit-$855,130K (-42.33%↓ Y/Y)Accumulated othercomprehensive loss-$333K (-1287.50%↓ Y/Y)Additional paid-in capital$1,380,535K (58.67%↑ Y/Y)Total currentliabilities$35,713K (56.10%↑ Y/Y)Operating leaseliabilities, net of current...$4,588K (10.77%↑ Y/Y)Common stock, 0.0001par value...$11K (22.22%↑ Y/Y)Accrued expenses andother current...$29,717K (63.12%↑ Y/Y)Accounts payable$5,996K (28.67%↑ Y/Y)

Immunome Inc. (IMNM)

Immunome Inc. (IMNM)